Financial Ratios

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE1588.804.6 (+0.29 %)
PREV CLOSE ( ) 1584.20
OPEN PRICE ( ) 1580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 441
TODAY'S LOW / HIGH ( )1576.85 1595.95
52 WK LOW / HIGH ( )921 1727
NSE1589.204.55 (+0.29 %)
PREV CLOSE( ) 1584.65
OPEN PRICE ( ) 1584.65
BID PRICE (QTY) 1589.20 (93)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24819
TODAY'S LOW / HIGH( ) 1573.10 1595.00
52 WK LOW / HIGH ( )921.1 1729
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)18.6615.2313.5110.477.51
   CEPS(Rs)24.4620.7018.3414.9211.63
   DPS(Rs)3.002.502.502.002.00
   Book NAV/Share(Rs)128.39112.1499.4248.6343.01
   Tax Rate(%)24.4025.0125.3024.1434.04
Margin Ratios
   Core EBITDA Margin(%)24.8324.2128.0024.9922.71
   EBIT Margin(%)23.0322.6424.4021.8019.27
   Pre Tax Margin(%)22.0822.0423.0818.7617.03
   PAT Margin (%)16.6916.5217.2414.2311.23
   Cash Profit Margin (%)21.8822.4723.4020.2817.40
Performance Ratios
   ROA(%)12.2211.3912.9312.9010.91
   ROE(%)15.5214.4018.7422.8518.58
   ROCE(%)19.3417.6821.6224.6422.92
   Asset Turnover(x)0.730.690.750.910.97
   Sales/Fixed Asset(x)1.241.241.251.281.34
   Working Capital/Sales(x)2.201.641.445.544.03
Efficiency Ratios
   Fixed Capital/Sales(x)0.810.800.800.780.74
   Receivable days70.1870.3065.4468.7573.01
   Inventory Days56.6753.6251.1049.2144.13
   Payable days94.7693.55107.80131.38111.54
Valuation Parameters
   PER(x)51.0762.3160.5322.5128.89
   PCE(x)38.9745.8344.5915.7918.66
   Price/Book(x)7.428.468.224.845.05
   Yield(%)0.310.260.310.850.92
   EV/Net Sales(x)8.5210.4610.623.483.43
   EV/Core EBITDA(x)30.0836.4234.5512.4213.41
   EV/EBIT(x)36.8545.9843.2815.8717.70
   EV/CE(x)5.706.906.452.913.05
   M Cap / Sales8.5610.3510.493.223.26
Growth Ratio
   Net Sales Growth(%)21.4617.6615.6610.1415.39
   Core EBITDA Growth(%)19.8110.0027.0020.5210.42
   EBIT Growth(%)23.469.1429.5324.525.77
   PAT Growth(%)22.6212.7440.1939.37-5.58
   EPS Growth(%)22.5612.7229.0339.36-5.59
Financial Stability Ratios
   Total Debt/Equity(x)0.110.100.130.440.40
   Current Ratio(x)2.493.653.671.561.90
   Quick Ratio(x)1.932.913.111.081.44
   Interest Cover(x)24.2337.3018.437.168.63
   Total Debt/Mcap(x)0.010.010.020.090.08

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.